Next week BioIVT will attend the Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting and the Alzheimer's Association International Conference (AAIC) WESTBURY, N.Y. , July 25, 2024 /PRNewswire/ -- BioIVT , a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced it will attend two leading industry conferences focused on research and developments for both general and neurodegenerative disease diagnostics and treatments.
From July 28 - August 1 , one group of BioIVT's experts will attend ADLM 2024 in Chicago , and another team will simultaneously attend AAIC 2024 in Philadelphia . BioIVT will have a booth at each event where the company will detail how BioIVT fuels innovative research for a comprehensive range of diseases. At ADLM, BioIVT will focus on support for diagnostic lab medicine, including clinically collected biospecimens across a broad range of disease indications, normal human and animal biofluids such as whole blood plasma and serum from any commercially available animal strain, as well as donor center quality control matrices from its KEYSTONE facility .
At AAIC, BioIVT will focus on support for Alzheimer's, Parkinson's, Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS), by providing high-quality biospecimens and research services to the life science industry. Launched in 2023 , BioIVT's Center for NeuroExcellence gives researchers across the world near-immediate access to ne.
